Neuropace Stock Investor Sentiment

NPCE Stock  USD 8.98  0.09  0.99%   
About 57% of Neuropace's investor base is looking to short. The analysis of overall sentiment of trading Neuropace stock suggests that many investors are alarmed at this time. The current market sentiment, together with Neuropace's historical and current headlines, can help investors time the market. In addition, many technical investors use Neuropace stock news signals to limit their universe of possible portfolio assets.

Comfort Level 43

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Neuropace's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Neuropace.

Neuropace Historical Sentiment

Although Neuropace's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Neuropace, such as negative comments on social media and news outlets, may cause fear in the market and push Neuropace's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Neuropace.

Neuropace Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Neuropace can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Neuropace Historical Investor Sentiment

Investor biases related to Neuropace's public news can be used to forecast risks associated with an investment in Neuropace. The trend in average sentiment can be used to explain how an investor holding Neuropace can time the market purely based on public headlines and social activities around Neuropace. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Neuropace's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Neuropace and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Neuropace news discussions. The higher the estimate score, the more favorable the investor's outlook on Neuropace.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Neuropace's Stock prices. Below is the latest headlines and news related to Neuropace Stock. The global stock market is bearish. About 62% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Neuropace that are available to investors today. This information is accessible both publicly - through Neuropace's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Neuropace-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Neuropace news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neuropace relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neuropace's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neuropace alpha.

Neuropace Largest EPS Surprises

Earnings surprises can significantly impact Neuropace's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-13
2024-06-30-0.3-0.260.0413 
2021-11-10
2021-09-30-0.3-0.34-0.0413 
2025-03-03
2024-12-31-0.2233-0.180.043319 
2023-05-04
2023-03-31-0.46-0.410.0510 
2024-11-12
2024-09-30-0.27-0.190.0829 
2024-03-05
2023-12-31-0.31-0.230.0825 
View All Earnings Estimates
a day ago at news.google.com         
NeuroPace Inc. Stock Analysis and Forecast - Outstanding risk-reward balance - PrintWeekIndia
Google News at Macroaxis
few days ago at news.google.com         
Acquisition by Lacob Joseph of 2505 shares of Neuropace at 4.49 subject to Rule 16b-3
Google News at Macroaxis
six days ago at news.google.com         
What drives NeuroPace Inc. stock price - Breakthrough stock performance - Jammu Links News
Google News at Macroaxis
over a week ago at www.macroaxis.com         
Acquisition by Kumar Rakhi of 1247 shares of Neuropace at 12.02 subject to Rule 16b-3
Macroaxis News
over a week ago at zacks.com         
AngioDynamics Reports Q4 Loss, Tops Revenue Estimates
zacks News
over a week ago at www.macroaxis.com         
Acquisition by Geiger Uri of 2337 shares of Neuropace at 4.49 subject to Rule 16b-3
Macroaxis News
over two weeks ago at globenewswire.com         
INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NP...
Macroaxis News: globenewswire.com
over two weeks ago at gurufocus.com         
INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. ...
Gurufocus Stories at Macroaxis
over three weeks ago at globenewswire.com         
INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NP...
Macroaxis News: globenewswire.com
over three weeks ago at gurufocus.com         
INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. ...
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
NeuroPace Inc Trading 3.92 percent Higher on Jun 30
Gurufocus Stories at Macroaxis
over three weeks ago at news.google.com         
NeuroPace - Volatile, Uncertain, But Promising - Seeking Alpha
Google News at Macroaxis
over three weeks ago at globenewswire.com         
INVESTOR ALERT Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of NeuroPace, Inc. - NPC...
Macroaxis News: globenewswire.com
over three weeks ago at gurufocus.com         
INVESTOR ALERT Pomerantz Law Firm Investigates ClaimsOn Behalf
Gurufocus Stories at Macroaxis
over three weeks ago at thelincolnianonline.com         
NeuroPace, Inc. Receives 15.50 Average PT from Analysts
news
There is far too much social signal, news, headlines, and media speculation about Neuropace that are available to investors today. This information is accessible both publicly - through Neuropace's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Neuropace-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Neuropace news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neuropace relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neuropace's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neuropace alpha.

Neuropace Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
NeuroPace Price Target Raised to 16.00
05/15/2025
2
Disposition of 3051 shares by Martha Morrell of Neuropace at 17.99 subject to Rule 16b-3
05/20/2025
3
NeuroPace Receives Positive Initiation from H.C. Wainwright NPCE Stock News
05/28/2025
4
Disposition of 1338 shares by Martha Morrell of Neuropace at 13.54 subject to Rule 16b-3
06/03/2025
5
INVESTOR ALERT Pomerantz Law Firm Investigates ClaimsOn Behalf
06/10/2025
6
INVESTOR ALERT Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of NeuroPace, Inc. - NPCE
06/18/2025
7
Acquisition by Fischer Frank M of 2281 shares of Neuropace at 10.41 subject to Rule 16b-3
06/20/2025
8
INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
06/23/2025
9
NeuroPace Announces Strategic CFO Transition NPCE Stock News
06/24/2025
10
NeuroPace Inc Trading Down 3.93 percent on Jun 27
06/27/2025
11
INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. ...
07/01/2025
12
Acquisition by Geiger Uri of 2337 shares of Neuropace at 4.49 subject to Rule 16b-3
07/11/2025
13
Acquisition by Kumar Rakhi of 1247 shares of Neuropace at 12.02 subject to Rule 16b-3
07/17/2025
14
NeuroPace Inc. Stock Analysis and Forecast - Outstanding risk-reward balance - PrintWeekIndia
07/25/2025

Complementary Tools for Neuropace Stock analysis

When running Neuropace's price analysis, check to measure Neuropace's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuropace is operating at the current time. Most of Neuropace's value examination focuses on studying past and present price action to predict the probability of Neuropace's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuropace's price. Additionally, you may evaluate how the addition of Neuropace to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Global Correlations
Find global opportunities by holding instruments from different markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments